3 results match your criteria: "Universita' di Genova and Istituto Nazionale per la Ricerca sul Cancro[Affiliation]"
J Cell Biochem
October 2010
Dipartimento di Oncologia, Biologia e Genetica, Universita' di Genova and Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Stalled cell division in precursor bone cells and reduced osteoblast function are considered responsible for the microgravity-induced bone loss observed during spaceflight. However, underlying molecular mechanisms remain unraveled. Having overcome technological difficulties associated with flying cells in a space mission, we present the first report on the behavior of the potentially osteogenic murine bone marrow stromal cells (BMSC) in a 3D culture system, flown inside the KUBIK aboard space mission ISS 12S (Soyuz TMA-8 + Increment 13) from March 30 to April 8, 2006 (experiment "Stroma-2").
View Article and Find Full Text PDFAm J Hematol
February 1999
Dipartimento di Oncologia Clinica e Sperimentale, Universitá di Genova and Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Recent reports have suggested a previously unexpected variability in the expression of the dominant neoplastic clone in myeloproliferative disorders (MPD). We evaluated 49 female patients with MPD and informative at the X-linked androgen receptor (AR) locus to establish the X chromosome inactivation pattern of hemopoietic cells. Whereas in chronic myelogenous leukemia (CML) the granulocytes (PMN) were uniformly of monoclonal origin, a striking heterogeneity of clonal development was found in PMN from patients with other MPD, with up to 50% of them expressing a polyclonal pattern of X inactivation.
View Article and Find Full Text PDFBlood Cells Mol Dis
December 1998
Dipartimento di Oncologia Clinica e Sperimentale, Università di Genova and Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Since one of the two X chromosomes is randomly inactivated at an early stage of female embryonic development, X-linked markers have been used to study the origin and development of various neoplastic disorders in affected heterozygous women; clonality assays have provided a useful tool to the understanding of the mechanisms underlying the development of neoplasia. Recently, a technique of clonal analysis has been devised that takes advantage of a highly polymorphic short tandem repeat within the X-linked human androgen receptor (AR) gene, resulting in a heterozygosity rate approaching 90%. The rapid expansion of the number of women now suitable for X inactivation analysis has however given rise to new controversies, one of the more troublesome being the possibility of a modification of the pattern of X- chromosome inactivation pattern in blood cells of elderly women.
View Article and Find Full Text PDF